181 related articles for article (PubMed ID: 28809615)
1. Does access to private healthcare influence potential lung cancer cure rates?
John TJ; Plekker D; Irusen EM; Koegelenberg CFN
S Afr Med J; 2017 Jul; 107(8):687-690. PubMed ID: 28809615
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Systemic Treatment Use in Advanced-stage Non-Small Cell Lung Cancer by Source of Health Insurance.
Maguire FB; Morris CR; Parikh-Patel A; Cress RD; Keegan THM; Li CS; Lin PS; Kizer KW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1059-1066. PubMed ID: 30842132
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
4. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
[TBL] [Abstract][Full Text] [Related]
5. An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes.
Slatore CG; Au DH; Gould MK;
Am J Respir Crit Care Med; 2010 Nov; 182(9):1195-205. PubMed ID: 21041563
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of
Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
[TBL] [Abstract][Full Text] [Related]
7. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
[TBL] [Abstract][Full Text] [Related]
8. Treatment variation by insurance status for breast cancer patients.
Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
[TBL] [Abstract][Full Text] [Related]
9. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Yorio JT; Yan J; Xie Y; Gerber DE
Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
[TBL] [Abstract][Full Text] [Related]
11. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
[TBL] [Abstract][Full Text] [Related]
12. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
13. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
[TBL] [Abstract][Full Text] [Related]
14. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
Rice SR; Vyfhuis MAL; Scilla KA; Burrows WM; Bhooshan N; Suntharalingam M; Edelman MJ; Feliciano J; Badiyan SN; Simone CB; Bentzen SM; Feigenberg SJ; Mohindra P
Clin Lung Cancer; 2020 May; 21(3):e130-e141. PubMed ID: 31708388
[TBL] [Abstract][Full Text] [Related]
15. Matched-Pair Analysis of High Dose Versus Standard Dose Definitive Chemoradiation for Locally Advanced Non-Small-Cell Lung Cancer.
Johnson MD; Sura K; Mangona VS; Glick A; Wallace M; Ye H; Grills IS
Clin Lung Cancer; 2017 Mar; 18(2):149-155. PubMed ID: 27426973
[TBL] [Abstract][Full Text] [Related]
16. The relation between health insurance coverage and clinical outcomes among women with breast cancer.
Ayanian JZ; Kohler BA; Abe T; Epstein AM
N Engl J Med; 1993 Jul; 329(5):326-31. PubMed ID: 8321261
[TBL] [Abstract][Full Text] [Related]
17. Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer.
Shin JY; Yoon JK; Marwaha G
Lung; 2018 Jun; 196(3):351-358. PubMed ID: 29550987
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.
Sher DJ; Liptay MJ; Fidler MJ
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):303-12. PubMed ID: 24685443
[TBL] [Abstract][Full Text] [Related]
19. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy.
Lee H; Jin GY; Han YM; Chung GH; Lee YC; Kwon KS; Lynch D
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):343-50. PubMed ID: 21626257
[TBL] [Abstract][Full Text] [Related]
20. The impact of HIV infection on the presentation of lung cancer in South Africa.
Koegelenberg CF; Van der Made T; Taljaard JJ; Irusen EM
S Afr Med J; 2016 Jun; 106(7):666-8. PubMed ID: 27384354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]